The Association Between Aortic Stenosis and the Risk of Consecutive Eyelid Inflammatory Diseases

Overview

Journal Int J Med Sci

Specialty General Medicine

Date 2025 Mar 3

PMID 40027196

Authors

Shu-Ling Peng

Tung-Lin Tsui

Ke-Hsin Ting

Yasser Nassef

Chia-Yi Lee

Jing-Yang Huang

Chao-Bin Yeh

Chia-Jui Weng

Shun-Fa Yang

Affiliations

Soon will be listed here.

Abstract

Aortic stenosis (AS) is a fatal cardiovascular disease characterized by an inflammatory response. Blepharitis and hordeolum are two eyelid conditions that also involve ocular inflammation. The aim of this study is to assess the association between AS and the subsequent development of eyelid inflammatory diseases. This retrospective cohort study included individuals diagnosed with AS, who were matched to a control group of non-AS individuals from the TriNetX database. A total of 431,027 individuals were assigned to both the AS and non-AS groups. The primary outcomes of this study were the incidence rates of eyelid inflammatory diseases, including blepharitis and hordeolum. Cox proportional hazards regression was used for statistical analysis. After the follow-up period, 4,464 cases of blepharitis were recorded in the AS group, compared to 3,139 in the non-AS group. Additionally, there were 2,184 cases of hordeolum in the AS group, compared to 1,724 in the non-AS group. Cox proportional hazards regression analysis revealed that the AS group had a significantly higher risk of developing blepharitis (P < 0.001) and hordeolum (P < 0.001) compared to the non-AS group. The AS group also showed significantly higher cumulative probabilities of both blepharitis and hordeolum than the non-AS group (both P < 0.001). In subgroup analyses, AS patients exhibited a higher risk of developing blepharitis than the non-AS population, except for the Asian population and individuals aged 20-45 years. Similarly, the AS group showed a higher risk of developing hordeolum than the non-AS group, with exceptions in the African and Asian populations and individuals aged 20-45 years. In conclusion, the presence of AS is associated with a higher risk of developing subsequent eyelid inflammatory diseases.

References

Boskovski M, Gleason T . Current Therapeutic Options in Aortic Stenosis. Circ Res. 2021; 128(9):1398-1417. DOI: 10.1161/CIRCRESAHA.121.318040. View

Cavone L, Muzzi M, Mencucci R, Sparatore B, Pedrazzi M, Moroni F . 18β-glycyrrhetic acid inhibits immune activation triggered by HMGB1, a pro-inflammatory protein found in the tear fluid during conjunctivitis and blepharitis. Ocul Immunol Inflamm. 2011; 19(3):180-5. DOI: 10.3109/09273948.2010.538121. View

Minvielle Moncla L, Briend M, Bosse Y, Mathieu P . Calcific aortic valve disease: mechanisms, prevention and treatment. Nat Rev Cardiol. 2023; 20(8):546-559. DOI: 10.1038/s41569-023-00845-7. View

Chen H, Dina C, Small A, Shaffer C, Levinson R, Helgadottir A . Dyslipidemia, inflammation, calcification, and adiposity in aortic stenosis: a genome-wide study. Eur Heart J. 2023; 44(21):1927-1939. PMC: 10232274. DOI: 10.1093/eurheartj/ehad142. View

Rhee M, Yeu E, Barnett M, Rapuano C, Dhaliwal D, Nichols K . Demodex Blepharitis: A Comprehensive Review of the Disease, Current Management, and Emerging Therapies. Eye Contact Lens. 2023; 49(8):311-318. PMC: 10351901. DOI: 10.1097/ICL.0000000000001003. View

Zheng K, Tzolos E, Dweck M . Pathophysiology of Aortic Stenosis and Future Perspectives for Medical Therapy. Cardiol Clin. 2019; 38(1):1-12. DOI: 10.1016/j.ccl.2019.09.010. View

Lindsley K, Nichols J, Dickersin K . Non-surgical interventions for acute internal hordeolum. Cochrane Database Syst Rev. 2017; 1:CD007742. PMC: 5370090. DOI: 10.1002/14651858.CD007742.pub4. View

Phillips D . Aortic stenosis: A review. AANA J. 2006; 74(4):309-15. View

Lee C, Yang S, Chang Y, Huang J, Chang C . The Degrees of Coronary Heart Disease and the Degrees of New-Onset Blepharitis: A Nationwide Cohort Study. Diagnostics (Basel). 2024; 14(13). PMC: 11240815. DOI: 10.3390/diagnostics14131349. View

10.

Peters A, Duggan J, Trachiotis G, Antevil J . Epidemiology of Valvular Heart Disease. Surg Clin North Am. 2022; 102(3):517-528. DOI: 10.1016/j.suc.2022.01.008. View

11.

Thaden J, Nkomo V, Enriquez-Sarano M . The global burden of aortic stenosis. Prog Cardiovasc Dis. 2014; 56(6):565-71. DOI: 10.1016/j.pcad.2014.02.006. View

12.

Harris A, Pibarot P, Otto C . Aortic Stenosis: Guidelines and Evidence Gaps. Cardiol Clin. 2019; 38(1):55-63. DOI: 10.1016/j.ccl.2019.09.003. View

13.

Gordon A, Danek D, Phelps P . Common inflammatory and infectious conditions of the eyelid. Dis Mon. 2020; 66(10):101042. DOI: 10.1016/j.disamonth.2020.101042. View

14.

Lindman B, Clavel M, Mathieu P, Iung B, Lancellotti P, Otto C . Calcific aortic stenosis. Nat Rev Dis Primers. 2016; 2():16006. PMC: 5127286. DOI: 10.1038/nrdp.2016.6. View

15.

Rassa A, Zahr F . Hypertension and Aortic Stenosis: A Review. Curr Hypertens Rev. 2018; 14(1):6-14. DOI: 10.2174/1573402114666180416161326. View

16.

Chen J, Lyu L, Shen J, Pan Y, Jing J, Wang Y . Epidemiological study of calcified aortic valve stenosis in a Chinese community population. Postgrad Med J. 2023; 99(1174):868-874. DOI: 10.1136/pmj-2022-141721. View

17.

Bernardes T, Bonfioli A . Blepharitis. Semin Ophthalmol. 2010; 25(3):79-83. DOI: 10.3109/08820538.2010.488562. View

18.

Frattini S, Troise G, Fucci C, Pressman G, Faggiano P . Aortic valve stenosis and cancer: a common and complex association. Expert Rev Cardiovasc Ther. 2021; 19(4):289-299. DOI: 10.1080/14779072.2021.1902306. View

19.

Amescua G, Akpek E, Farid M, Garcia-Ferrer F, Lin A, Rhee M . Blepharitis Preferred Practice Pattern®. Ophthalmology. 2018; 126(1):P56-P93. DOI: 10.1016/j.ophtha.2018.10.019. View

20.

Kanwar A, Thaden J, Nkomo V . Management of Patients With Aortic Valve Stenosis. Mayo Clin Proc. 2018; 93(4):488-508. DOI: 10.1016/j.mayocp.2018.01.020. View